Multimorbidity: A challenge for evidence-based medicine

Evidence-Based Medicine

Volumn 15, Issue 6, 2010, Pages 165-166

  Campbell Scherer, Denise ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; COMORBIDITY; EDITORIAL; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; MORBIDITY; MULTIMORBIDITY; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; RISK BENEFIT ANALYSIS;

CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; MORBIDITY; PRIMARY HEALTH CARE;

EID: 78649880930     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebm1154     Document Type: Editorial

References (20)

1. Saitz R. Evidence-based medicine: time for transition and translation (to practice). Evid Based Med 2010;15:103-4.
2. Akker M vd, Buntinx F, Knottnerus A. Comorbidity or multimorbidity: what's in a name? A review of literature. Eur J Gen Pract 1996;2:65-70.
3. Fortin M, Dionne J, Pinho G, et al. Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med 2006;4:104-8.
4. Hoffman C, Rice D, Sung HY. Persons with chronic conditions. Their prevalence and costs. JAMA 1996;276:1473-9.
5. Wu SY, Green A. Projection of Chronic Illness Prevalence and Cost Inflation. Washington, DC: RAND Health 2000.
6. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002;162:2269-76. (Pubitemid 35332510)
7. Chan AW, Hróbjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457-65. (Pubitemid 38669189)
8. Bero L, Oostvogel F, Bacchetti P, et al. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med 2007;4:e184.
9. Buchkowsky SS, Jewesson PJ. Industry sponsorship and authorship of clinical trials over 20 years. Ann Pharmacother 2004;38:579-85.
10. Bassler D, Montori VM, Briel M, et al. Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol 2008;61:241-6.
11. Montori VM, Jaeschke R, Schünemann HJ, et al. Users' guide to detecting misleading claims in clinical research reports. BMJ 2004;329:1093-6.
12. Scott IA, Guyatt GH. Cautionary tales in the interpretation of clinical studies involving older persons. Arch Intern Med 2010;170:587-95.
13. Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831-41.
14. Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
15. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005;294:716-24. (Pubitemid 41159291)
16. Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn't. BMJ 1996;312:71-2.
17. Edward A, Elwyn G, eds. Shared Decision-Making in Health Care. Achieving Evidence-Based Patient Choice. Second edition. Oxford UK, Oxford University Press 2009: 3-10.
18. Braithwaite RS, Concato J, Chang CC, et al. A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med 2007;167:2361-5.
19. Sun X, Briel M, Walter SD, et al. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010;340:c117.
20. White KL. Fundamental research at primary care level. Lancet 2000;355:1904-6.